Regeneron Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
REGN Nasdaq 8731 https://www.regeneron.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Regeneron Pharmaceuticals Inc

Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD - Sep 30th, 2024 7:00 pm
Regeneron, Sanofi announce Dupixent approval in China for patients with COPD - Sep 28th, 2024 11:05 am
Jim Cramer on Regeneron Pharmaceuticals Inc. (REGN): ‘Leerink Analysts Downgraded Regeneron To A Market Perform Hold After A Negative Eylea 2mg Biosimilar Preliminary Injunction Ruling’ - Sep 28th, 2024 10:33 am
Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD - Sep 27th, 2024 8:51 pm
Regeneron Shares Head for Worst Month Since 2019 on Legal Ruling - Sep 27th, 2024 8:39 pm
FDA greenlights Regeneron’s Dupixent for the treatment of COPD - Sep 27th, 2024 6:53 pm
Sanofi/Regeneron’s Dupixent set to dominate COPD biologics market following FDA approval - Sep 27th, 2024 4:13 pm
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD - Sep 27th, 2024 2:24 pm
Regeneron And Sanofi Snag Their $6 Billion-Potential COPD Approval For Dupixent - Sep 27th, 2024 1:36 pm
Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD - Sep 27th, 2024 1:35 pm
Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD) - Sep 27th, 2024 11:00 am
FDA, after delay, clears Regeneron and Sanofi drug for COPD - Sep 27th, 2024 9:35 am
Regeneron to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on October 31, 2024 - Sep 26th, 2024 8:05 pm
Amgen Stock Falls on Disappointing Drug Data - Sep 25th, 2024 4:54 pm
US Equity Indexes Rise as Sliding Consumer Confidence Undermines Bowman's Call for Policy Caution - Sep 24th, 2024 5:41 pm
Regeneron Stock Down on Court Ruling for Amgen's Biosimilar of Eylea - Sep 24th, 2024 5:09 pm
Regeneron slump continues as analysts turn more cautious - Sep 24th, 2024 4:19 pm
HRMY vs. REGN: Which Stock Should Value Investors Buy Now? - Sep 24th, 2024 3:40 pm
Regeneron Stock Slides After Court Rejects Injunction Against Eye Drug Biosimilar, Truist Says - Sep 23rd, 2024 9:27 pm
Tesla Leads S&P 500 Index, While Biotech Giant Tumbles On Court Ruling - Sep 23rd, 2024 8:34 pm